Aloglutamol
Aloglutamol can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum
Aluminium can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Asenapine
Asenapine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Benazepril
The risk or severity of adverse effects can be increased when Benazepril is combined with Iron Dextran.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Captopril
The risk or severity of adverse effects can be increased when Captopril is combined with Iron Dextran.
Cefdinir
The serum concentration of Cefdinir can be decreased when it is combined with Iron Dextran.
Chlortetracycline
Chlortetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cilazapril
The risk or severity of adverse effects can be increased when Cilazapril is combined with Iron Dextran.
Cimetidine
Cimetidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cinoxacin
The serum concentration of Cinoxacin can be decreased when it is combined with Iron Dextran.
Ciprofloxacin
The serum concentration of Ciprofloxacin can be decreased when it is combined with Iron Dextran.
Clofezone
Rabeprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Iron Dextran.
Demeclocycline
Demeclocycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dibasic potassium phosphate
Iron Dextran can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dimercaprol
Dimercaprol may increase the nephrotoxic activities of Iron Dextran.
Dolutegravir
The serum concentration of Dolutegravir can be decreased when it is combined with Iron Dextran.
Doxepin
Doxepin can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline
Doxycycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline Anhydrous
Doxycycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Eltrombopag
The serum concentration of Eltrombopag can be decreased when it is combined with Iron Dextran.
Enalapril
The risk or severity of adverse effects can be increased when Enalapril is combined with Iron Dextran.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Iron Dextran.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Iron Dextran.
Enoxacin
The serum concentration of Enoxacin can be decreased when it is combined with Iron Dextran.
Epinastine
Epinastine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Esomeprazole
Esomeprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Famotidine
Famotidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fleroxacin
The serum concentration of Fleroxacin can be decreased when it is combined with Iron Dextran.
Flumequine
The serum concentration of Flumequine can be decreased when it is combined with Iron Dextran.
Fosinopril
The risk or severity of adverse effects can be increased when Fosinopril is combined with Iron Dextran.
Gatifloxacin
The serum concentration of Gatifloxacin can be decreased when it is combined with Iron Dextran.
Gatifloxacin Anhydrous
The serum concentration of Gatifloxacin can be decreased when it is combined with Iron Dextran.
Gemifloxacin
The serum concentration of Gemifloxacin can be decreased when it is combined with Iron Dextran.
Gemifloxacin Mesylate
The serum concentration of Gemifloxacin can be decreased when it is combined with Iron Dextran.
Grepafloxacin
The serum concentration of Grepafloxacin can be decreased when it is combined with Iron Dextran.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Iron Dextran.
Lansoprazole
Lansoprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levodopa
The serum concentration of Levodopa can be decreased when it is combined with Iron Dextran.
Levofloxacin
The serum concentration of Levofloxacin can be decreased when it is combined with Iron Dextran.
Levofloxacin Anhydrous
The serum concentration of Levofloxacin can be decreased when it is combined with Iron Dextran.
Levothyroxine
The serum concentration of Levothyroxine can be decreased when it is combined with Iron Dextran.
Lisinopril
The risk or severity of adverse effects can be increased when Lisinopril is combined with Iron Dextran.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Lisinopril is combined with Iron Dextran.
Lomefloxacin
The serum concentration of Lomefloxacin can be decreased when it is combined with Iron Dextran.
Magaldrate
Magaldrate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methantheline
Methantheline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methyldopa
The serum concentration of Methyldopa can be decreased when it is combined with Iron Dextran.
METHYLDOPA ANHYDROUS
The serum concentration of Methyldopa can be decreased when it is combined with Iron Dextran.
Minocycline
Minocycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Moexipril
The risk or severity of adverse effects can be increased when Moexipril is combined with Iron Dextran.
Moxifloxacin
The serum concentration of Moxifloxacin can be decreased when it is combined with Iron Dextran.
Nalidixic Acid
The serum concentration of Nalidixic Acid can be decreased when it is combined with Iron Dextran.
Nizatidine
Nizatidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Norfloxacin
The serum concentration of Norfloxacin can be decreased when it is combined with Iron Dextran.
Ofloxacin
The serum concentration of Ofloxacin can be decreased when it is combined with Iron Dextran.
Olanzapine
Olanzapine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Omeprazole
Omeprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxytetracycline
Oxytetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxytetracycline Anhydrous
Oxytetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pancreatin
Pancrelipase can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pancrelipase
Pancrelipase can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
PANCRELIPASE PROTEASE
Pancrelipase can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pantoprazole
Pantoprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pefloxacin
The serum concentration of Pefloxacin can be decreased when it is combined with Iron Dextran.
Penicillamine
Iron Dextran can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Perindopril
The risk or severity of adverse effects can be increased when Perindopril is combined with Iron Dextran.
Promethazine
Promethazine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quinapril
The risk or severity of adverse effects can be increased when Quinapril is combined with Iron Dextran.
Rabeprazole
Rabeprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ramipril
The risk or severity of adverse effects can be increased when Ramipril is combined with Iron Dextran.
Ranitidine
Ranitidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rescinnamine
The risk or severity of adverse effects can be increased when Rescinnamine is combined with Iron Dextran.
Rosoxacin
The serum concentration of Rosoxacin can be decreased when it is combined with Iron Dextran.
Roxatidine Acetate
Roxatidine acetate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium glycerophosphate
Iron Dextran can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Iron Dextran can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Iron Dextran can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate, Monobasic
Iron Dextran can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Iron Dextran can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sparfloxacin
The serum concentration of Sparfloxacin can be decreased when it is combined with Iron Dextran.
Spirapril
The risk or severity of adverse effects can be increased when Spirapril is combined with Iron Dextran.
Temafloxacin
The serum concentration of Temafloxacin can be decreased when it is combined with Iron Dextran.
Tetracycline
Tetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thioctic Acid
Iron Dextran can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trandolapril
The risk or severity of adverse effects can be increased when Trandolapril is combined with Iron Dextran.
Trientine
The serum concentration of Iron Dextran can be decreased when it is combined with Triethylenetetramine.
Tromethamine
Tromethamine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trovafloxacin
The serum concentration of Trovafloxacin can be decreased when it is combined with Iron Dextran.
Zofenopril
The risk or severity of adverse effects can be increased when Zofenopril is combined with Iron Dextran.
